Adnexal Mass
23
5
5
9
Key Insights
Highlights
Success Rate
69% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
17.4%
4 terminated out of 23 trials
69.2%
-17.3% vs benchmark
0%
0 trials in Phase 3/4
33%
3 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (23)
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
ICG-Enabled Mapping of Ovarian Sentinel Lymph Nodes: A Feasibility Study
Comparing Intrathecal Morphine and Intraoperative Lidocaine Infusion to Epidural Anesthesia With Postoperative PCA for Patients Undergoing Exploratory Laparotomy
Contrast-Enhanced Subharmonic Ultrasound Imaging in Improving Characterization of Adnexal Masses in Patients Undergoing Surgery
A Clinical Study on the Feasibility and Safety of Abdominal Endoscopic Single-port Surgery System to Assist Gynecological Day Surgery
Assessment of Women's Sexual Quality of Life After Benign Adnexal Surgery Using vNOTES Approach
Masses in Young Patients - International Ovarian Tumour Analysis (MY-IOTA)
Research and Application of Ultrasonic Intelligent Diagnosis System for Ovarian Mass
Improved Diagnosis of Ovarian Cancer
Clinical Validation of the InterVenn Ovarian CAncer Liquid Biopsy
Diagnosis of Epithelial Ovarian Cancer Using Ovarian Cancer Score (OCS) Test
A Multivariate Index Assay for Ovarian Cancer Risk Assessment in Women With Adnexal Mass and High-Risk Germline Variants
Multifactorial Risk Assessment for Breast & Ovarian Cancer Risk Detection
Prospective Validation of the ADNEX Model for Discrimination Between Benign and Malignant Adnexal Masses in Pregnancy: International Ovarian Tumour Analysis in Pregnancy Study (p-IOTA)
Accuracy of the Characterization of Adnexal Masses, Indeterminate at Ultrasonography, Using a MRI Protocol Without Contrast: Validation of the Cambridge Score
Retrospective Review on PAEDIATRIC and ADOLESCENT ADNEXAL MASSES
Preoperative Care In Ovarian Cancer Patients
Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy
Natera Ovarian Cancer Detection Assay
Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer